Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-006724

Chief Executive Officer sold 21,704 shares at $7.23 ($156,811)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2025-01-15 Sale −21,704 $7.23 $156,811 251,912 D
Open-market sales · 21,704 sh · avg $7.23 · $156,811
Loading xslF345X05/ownership.xml…